ipilimumabinterferon alfa-2bmelanomadermatitis
…treicher H, Sondak VK, Kirkwood JM. Phase III study of adjuvant ipilimumab (3 or 10 mg/kg) versus high-dose interferon alfa-2b for resecte…
1articles mentioning drugs
1drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: interferon alfa-2b ×
interferon alfa-2b
This drug is selected. Its supporting articles are shown below.